Tobin Scientific Secures $65M in New Funding to Revolutionize Biopharma Cold Chain & Lab Logistics

Tobin Scientific, a renowned leader in biopharma cold chain, ambient storage, and transport & logistics services, is thrilled to announce a milestone funding achievement of $65,000,000. This significant capital infusion is set to accelerate our mission of delivering innovative logistical solutions and comprehensive support to the scientific and healthcare communities. With decades of experience partnering with lab managers, principal investigators, scientists, operations leaders, and facilities managers, we have built a reputation for managing complex projects that range from frozen biological transport and full laboratory relocations to mobile cold rooms, warehousing, and specialized biorepository services. The new funding will empower Tobin Scientific to expand our service offerings, enhance state-of-the-art storage and transport infrastructure, and further develop our emergency response capabilities, ensuring our clients continue to receive unparalleled service during critical times. This infusion of capital also positions us to invest in advanced technology and digital solutions that streamline communication, tracking, and compliance, providing our partners with real-time insights into temperature-sensitive shipments. Our commitment to research collaboration and innovation is central to everything we do, and this investment will help us build robust, scalable solutions to meet the rapidly evolving demands of the biopharma sector. As we embark on this exciting phase of growth, we are deeply grateful to our investors for their confidence in our vision and strategy. With renewed vigor and strengthened operational capacity, Tobin Scientific is ready to set new benchmarks in the industry, ensuring that critical scientific research and healthcare delivery are supported by the most reliable and efficient logistics services available.